Global OTC Consumer Health Products Market Insights, Forecast to 2028
SKU ID : QYR-20192393 | Publishing Date : 10-Feb-2022 | No. of pages : 112
Market Analysis and Insights: Global OTC Consumer Health Products Market
Due to the COVID-19 pandemic, the global OTC Consumer Health Products market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Skin Care Products accounting for % of the OTC Consumer Health Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
Based on indication, this TMR report segments the global OTC consumer health products market into skin care products, oral care products, nutritional supplements, gastrointestinal products, and wound care management products. In 2016, the nutritional supplements segment served the maximum demand, and is expected to remain most fruitful aspect of the market throughout the forecast period, which is primarily attributed to the growing demand for vitamins and dietary supplements and the sports nutrition products.
Global OTC Consumer Health Products Scope and Segment
OTC Consumer Health Products market is segmented by Type and by Application. Players, stakeholders, and other participants in the global OTC Consumer Health Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Skin Care Products
Oral Care Products
Nutritional Supplements
Wound Care Management Products
Gastrointestinal Products
Segment by Application
Hospital Pharmacy
Independent Pharmacies
Online Sales
Others
By Company
Pfizer
American Health
Abbott Laboratories
GlaxosmithKline
Ipsen, Sanofi
Bayer
Piramal Enterprises
Sun Pharmaceuticals
Glenmark Pharmaceuticals
Johnson & Johnson
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region